View in EDS

Prior response to anti-VEGF agents predicts the efficacy of trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer.

Saved in:
Bibliographic Details
Title: Prior response to anti-VEGF agents predicts the efficacy of trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer.
Authors: Hirakawa M; Division of Medical Oncology, Department of Internal Medicine, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Hokkaido, 060-8543, Japan. mhirakawa@sapmed.ac.jp., Sagawa T; Department of Gastroenterology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan., Okagawa Y; Division of Medical Oncology, Department of Internal Medicine, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Hokkaido, 060-8543, Japan., Suzuki N; Division of Medical Oncology, Department of Internal Medicine, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Hokkaido, 060-8543, Japan., Fujikawa K; Department of Gastroenterology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan., Takada K; Division of Medical Oncology, Department of Internal Medicine, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Hokkaido, 060-8543, Japan.
Source: International journal of clinical oncology [Int J Clin Oncol] 2026 Jul; Vol. 31 (7), pp. 1267-1274. Date of Electronic Publication: 2026 Apr 30.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1437-7772
DOI:10.1007/s10147-026-03035-w